Related Experiment Video
Updated: Apr 25, 2026

Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development
Published on: May 17, 2024
Cognitive and behavioral problems in children with neurofibromatosis type 1: challenges and future directions
Katherine E Schwetye1, David H Gutmann
1Department of Pathology, Division of Neuropathology, Washington University School of Medicine, Box 8111, 660 S. Euclid Avenue, St. Louis MO 63110, USA.
Insights
Neurofibromatosis type 1 (NF1) causes cognitive and behavioral disorders in most children. Research in animal models identifies promising therapeutic targets for learning, attention, and autism spectrum issues in NF1 patients.
Area of Science:
- Neuroscience
- Genetics
- Pediatrics
Background:
- Neurofibromatosis type 1 (NF1) is an inherited disorder associated with a high prevalence of cognitive and behavioral issues in children.
- These manifestations significantly impact patients and their families, with a wide range of clinical presentations including learning disabilities and autism spectrum disorder.
- The heterogeneity of NF1 phenotypes presents a challenge for developing effective therapeutic interventions.
Purpose of the Study:
- To provide an updated review of cognitive and behavioral disorders in neurofibromatosis type 1.
- To summarize current understanding and identified therapeutic targets based on small-animal models.
- To propose future research directions for improved therapeutic strategies and clinical trials.
Main Methods:
- Review of existing literature on NF1-associated cognitive and behavioral disorders.
- Analysis of findings from small-animal models of NF1.
- Synthesis of current knowledge to identify therapeutic targets.
Main Results:
- Cognitive and behavioral disorders are highly prevalent in NF1, affecting nearly 80% of affected children.
- Small-animal models have revealed several promising targets for addressing learning, attention, and autism spectrum phenotypes.
- Understanding the spectrum of NF1 phenotypes is crucial for therapeutic development.
Conclusions:
- Significant progress has been made in identifying potential therapeutic targets for NF1-related cognitive and behavioral disorders.
- Further research is needed to translate findings from animal models into effective human therapies.
- Future clinical trials should focus on targeted approaches for the diverse NF1 patient population.
Abstract:
Cognitive and behavioral disorders affect nearly 80% of all children with the neurofibromatosis type 1 inherited cancer syndrome, and are among the most significant clinical manifestations for patients and their families. One of the barriers to successful therapeutic intervention is the wide spectrum of clinical phenotypic expression, ranging from visuospatial learning problems to social perceptual deficits (autism). Leveraging numerous small-animal models of neurofibromatosis type 1, several promising targets have been identified to treat the learning, attention, and autism spectrum phenotypes in this at-risk population. In this review, we provide an up-to-date summary of our current understanding of these disorders in NF1, and propose future research directions aimed at designing more effective therapeutic approaches and clinical trials.
More Related Videos
Related Concept Videos
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Prosopagnosia
Information Processing Approach
Social Anxiety Disorder
Conduct Disorder

